Trial Information

Official Title: A Randomized, Prospective, Double-blind, Vehicle-controlled, Dose-ranging, Multi-center Study to Assess the Safety and Clinical Effect of Nexagon® in the Treatment of Subjects With a Diabetic Foot Ulcer

Summary

This study is for Type I or Type II diabetic subjects with with a diabetic foot ulcer. The study is being done to determine if Nexagon® plus standard of care is more effective than placebo plus standard of care. Standard of care will include debridement of the ulcer, standardized dressings and standardized off-loading using a Non-removable Cast Walker.

Phase: Phase 2

Sponsor: CoDa Therapeutics Inc.

Overall Contacts:

Alexis White, BSc
+64 9 376 0420
alexis@codanz.com

David Eisenbud, MD MBA FACS
Phone: +1 908 347 1617
DEisenbud@codatherapeutics.com